NCT04757532 Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT04634071 Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment Status COMPLETED Phase PHASE2
NCT04464577 A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235 Status WITHDRAWN Phase PHASE1
NCT04457180 A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects Status COMPLETED Phase PHASE1
NCT04446039 Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea Status COMPLETED Phase N/A
NCT04422652 Combination of Novel Therapies for CKD Comorbid Depression Status RECRUITING Phase PHASE2
NCT04388319 Zonisamide/Bupropion Effects on Switching to Electronic Cigarettes Status COMPLETED Phase PHASE3
NCT04388189 Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion Status WITHDRAWN Phase PHASE4
NCT04135937 Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH) Status COMPLETED Phase PHASE4
NCT03993457 Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression Status TERMINATED Phase PHASE4
NCT03950427 PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness Status COMPLETED Phase PHASE4
NCT03927950 Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) Treatment Status COMPLETED Phase PHASE4
NCT03897439 Individualizing Pharmacotherapy for African American Smokers Status COMPLETED Phase PHASE3
NCT03852160 A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression Status WITHDRAWN Phase PHASE3